Related Experiment Videos
De novo development of membranous nephropathy in cadaver renal allografts
Abstract:
Glomerulonephritis in transplant recipients often reflects recurrence of the immunopathogenetic mechanism causing the original renal disease. Membranous nephropathy (MN), a progressive immune complex mediated glomerular disease and the commonest cause of idiopathic nephrotic syndrome in adults, has been virtually unreported in transplant recipients. Two cases are reported here of typical MN (by clinical, light, immunofluorescent and electron microscopic criteria) developing de novo in the transplants of patients whose original diseases were anti-GBM nephritis and focal glomerular sclerosis. NM developed following episodes of viral hepatitis and renal infarction respectively. Possible mechanisms by which this lesion might develop in these patients are investigated and discussed. Chronic immune complex nephropathy (MN) can develop de novo in immunosuppressed transplant recipients apparently initiated by events in the post-transplant period.
Insights
Membranous nephropathy (MN), a kidney disease, can develop in organ transplant recipients. This study reports two cases of de novo MN in kidney transplants, suggesting new mechanisms beyond original disease recurrence.
Area of Science:
- Nephrology
- Transplant Immunology
- Glomerular Diseases
Background:
- Glomerulonephritis in transplant recipients typically results from the recurrence of the original disease's immunopathogenesis.
- Membranous nephropathy (MN), a common cause of adult nephrotic syndrome, is rarely reported in transplant recipients.
- The development of de novo glomerular diseases in transplanted kidneys is an area of significant clinical interest.
Purpose of the Study:
- To report and investigate the occurrence of de novo membranous nephropathy (MN) in kidney transplant recipients.
- To explore potential mechanisms underlying the development of MN in the post-transplant setting.
- To highlight that chronic immune complex nephropathy can arise de novo in immunosuppressed patients.
Main Methods:
- Case report of two kidney transplant recipients who developed de novo membranous nephropathy.
- Evaluation included clinical presentation, light microscopy, immunofluorescence, and electron microscopy.
- Analysis of patient history, including original renal disease and post-transplant events like viral hepatitis and renal infarction.
Main Results:
- Two cases of typical membranous nephropathy (MN) were diagnosed de novo in kidney transplants.
- The patients' original renal diseases were anti-GBM nephritis and focal glomerular sclerosis.
- MN development followed episodes of viral hepatitis and renal infarction, respectively.
Conclusions:
- Membranous nephropathy can develop de novo in immunosuppressed transplant recipients.
- Post-transplant events, such as viral infections or infarction, may initiate de novo MN.
- This finding expands the understanding of glomerular disease pathogenesis in the context of organ transplantation.